News

Team, Inc. Third Quarter 2024 Financial Performance Overview

Team, Inc. Third Quarter 2024 Financial Performance Overview

Overview of Team, Inc. Q3 2024 Financial Results

In its latest performance update, Team, Inc. (NYSE: TISI), a leading global provider of specialty industrial services, revealed its financial results for the third quarter. The company continues to demonstrate resilience in a competitive market, showcasing a slight revenue increase alongside initiatives intended to enhance operational efficiency.

Financial Highlights

During the third quarter, Team, Inc. achieved total revenues of $210.8 million, marking a modest rise of 2% compared to the same period last year. This growth is attributed to a **6% increase in the U.S. segment**, driven largely by heightened activity in inspection and heat treating services.

Despite the challenges faced in international markets, particularly in Canada, the company effective maneuvers in its core operations have led to a solid gross margin of **25.4%**. Additionally, Team, Inc. improved its operating income by **$4.4 million** year-over-year to reach $3.2 million. However, it reported a net loss of **$11.1 million**, reflecting improved performance by **8.3%** compared to last year.

Operational Insights

CEO Keith D. Tucker expressed optimism regarding growth strategies implemented across various segments. For instance, the Inspection and Heat Treating segment experienced a **33% improvement in Adjusted EBITDA**, evidencing the success of targeted customer initiatives focused on capturing higher-margin revenue. Moreover, the company achieved **free cash flow of $3.9 million**, a significant leap of **$4.7 million** from 2023, thanks to effective cash flow management strategies.

Focus on Margin Improvement

Looking ahead, Team, Inc. is intensifying its focus on sustaining margin improvements and managing costs more effectively. Recent actions are poised to yield annualized savings ranging from **$6 million to $8 million**. The management team remains committed to refining operational efficiencies and ensuring the long-term sustainability of the firm.

Future Outlook

As the company sets its sights on the next fiscal quarter and beyond, it anticipates a positive trajectory with healthy activity levels across all segments. Expectations for 2025 indicate low to mid-single-digit growth due to the implementation of successful commercial initiatives along with disciplined cost management. The target goal for Adjusted EBITDA margins remains at **10%**—a significant point of focus as they continue to project healthy financial performance.

Balance Sheet Position

As of September 30, 2024, Team, Inc. reported total liquidity of **$42.9 million**, complemented by cash and cash equivalents of **$14.9 million**. The total debt has increased to **$321.2 million**, primarily due to new financing and interest payments. Despite this, the management is strategically focused on maintaining a positive cash flow and maximizing operational efficiency.

Conclusion

Team, Inc. continues to navigate the complexities of the industrial services sector with a strategic approach to improving its performance metrics. With a dedicated focus on operational excellence, the company remains set on enhancing shareholder value and delivering results through its unique suite of services.

Frequently Asked Questions

What were Team, Inc.'s total revenues for Q3 2024?

Team, Inc. reported total revenues of $210.8 million for the third quarter of 2024.

How much did Team, Inc. enhance its operating income?

The company improved its operating income to $3.2 million, an increase of $4.4 million year-over-year.

What is the future outlook for Team, Inc.?

Team, Inc. expects low to mid-single-digit revenue growth in 2025, bolstered by effective cost management strategies.

How did the Adjusted EBITDA compare year-over-year?

Team, Inc. achieved an Adjusted EBITDA improvement of 33% in the Inspection and Heat Treating segment.

What steps is Team, Inc. taking for cost efficiency?

The company aims to generate annualized cost savings of $6 million to $8 million through targeted cost reduction initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Cirba Solutions Welcomes Angie Stoskopf as VP of HR

Updated Category News Views 124

Cirba Solutions Welcomes New Executive Leadership Cirba Solutions, the leading battery recycling materials and management company, has announced the recent appointment of Angie Stoskopf as Vice President of People & Talent. This strategic decision underscores the company's commitment to enhancing its human resources capabilities, enabling them to support continued growth...

Continue Reading
Stay Warm This Winter With Mini-Split Heating Solutions

Updated Category News Views 65

Discover Efficient Heating with Mini-Split Systems As winter approaches and temperatures begin to drop, many homeowners are searching for effective and energy-efficient heating solutions. Mr. Mini Split is a leading provider in offering innovative mini-split heating and cooling systems that enhance comfort while maintaining energy efficiency. Why Choose Mini-Split...

Continue Reading
Leadership Changes at TowerCom Following Chris Colton's Passing

Updated Category News Views 1029

TowerCom Announces Significant Leadership Changes TowerCom, a seasoned developer of cell towers for over three decades, is thrilled to unveil pivotal leadership appointments aimed at furthering its growth and operational success. The company has elevated George Davis to the position of Chief Executive Officer, Matt Richard has been promoted to Chief Financial Officer,...

Continue Reading
Tencent Music's Strategic Growth Amidst Listener Decline

Updated Category News Views 201

Tencent Music's Robust performance amidst challenges Tencent Music Entertainment (NYSE: TME) recently showcased its impressive quarterly growth, gaining attention in the market as its shares surged. The latest financial results highlighted a revenue of $1.19 billion, reflecting a remarkable 20.6% increase year-over-year (Y/Y), a sign of strong demand and resilience in the...

Continue Reading
Bowen Acquisition Corp. Stock Hits Notable Low Amid Market Struggles

Updated Category News Views 192

Bowen Acquisition Corp. Experiences Significant Stock Movement In a financial landscape characterized by considerable fluctuations, Bowen Acquisition Corp. (BOWN) has seen its stock drop to a new 52-week low, hitting $10.08. This dip is noteworthy for a company with a market capitalization of around $100 million, particularly since BOWN is often recognized for its...

Continue Reading